Two Sigma Investments LP decreased its position in Analogic Co. (NASDAQ:ALOG) by 13.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 56,345 shares of the medical research company’s stock after selling 8,472 shares during the period. Two Sigma Investments LP owned approximately 0.45% of Analogic worth $4,719,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Acadian Asset Management LLC bought a new stake in Analogic in the fourth quarter valued at $3,102,000. Bank of Montreal Can increased its stake in Analogic by 37.6% in the fourth quarter. Bank of Montreal Can now owns 52,237 shares of the medical research company’s stock valued at $4,375,000 after purchasing an additional 14,280 shares in the last quarter. Ameriprise Financial Inc. increased its stake in Analogic by 10.6% in the third quarter. Ameriprise Financial Inc. now owns 354,655 shares of the medical research company’s stock valued at $29,703,000 after purchasing an additional 34,021 shares in the last quarter. Legal & General Group Plc increased its stake in Analogic by 6.8% in the third quarter. Legal & General Group Plc now owns 25,362 shares of the medical research company’s stock valued at $2,125,000 after purchasing an additional 1,613 shares in the last quarter. Finally, Pinebridge Investments L.P. increased its stake in Analogic by 58.1% in the fourth quarter. Pinebridge Investments L.P. now owns 18,179 shares of the medical research company’s stock valued at $1,523,000 after purchasing an additional 6,681 shares in the last quarter. Institutional investors and hedge funds own 97.55% of the company’s stock.
Shares of Analogic stock opened at $91.60 on Friday. Analogic Co. has a 52 week low of $66.00 and a 52 week high of $101.80. The firm has a market cap of $1,145.09, a price-to-earnings ratio of -15.82, a price-to-earnings-growth ratio of 3.09 and a beta of 0.77.
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 26th. Stockholders of record on Thursday, March 15th will be given a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 0.44%. The ex-dividend date is Wednesday, March 14th. Analogic’s payout ratio is presently -6.91%.
ALOG has been the subject of several research analyst reports. BidaskClub downgraded shares of Analogic from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. Jefferies Group reaffirmed a “hold” rating and issued a $80.00 price target on shares of Analogic in a research note on Friday, December 8th. Finally, Zacks Investment Research raised shares of Analogic from a “hold” rating to a “buy” rating and set a $97.00 price target for the company in a research note on Friday, December 8th.
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Want to see what other hedge funds are holding ALOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Analogic Co. (NASDAQ:ALOG).
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.